An Interview With Founding Trustee Myron A. Hirsch
The first night, ten years ago, that Myron A. Hirsch put the Afternoon Edition, the Facial Pain Research Foundation’s web newspaper, online, he received an email.
The first night, ten years ago, that Myron A. Hirsch put the Afternoon Edition, the Facial Pain Research Foundation’s web newspaper, online, he received an email.
Orion P. Keifer, Jr., M.D., Ph.D., is Vice President for discovery and translation at CODA Biotherapeutics Inc. in South San Francisco, California. He is a neuroscientist with neurosurgical expertise in small and large animal models, focused on small molecule, biologics, and cell and gene therapies for neurological diseases.
Michael Pasternak, Ph.D., is a Founding Trustee of the Facial Pain Research Foundation. Dr. Pasternak spoke with Mervyn Rothstein, who was an editor and writer at The New York Times for 30 years.
Cory R. Nicholas, Ph.D., is a co-founder and chief scientific officer of Neurona Therapeutics. He is also an adjunct assistant professor at the University of California, San Francisco.
Wolfgang Liedtke, M.D., Ph. D., is a professor in the Departments of Neurology, Anesthesiology and Neurobiology at Duke University in Durham, North Carolina.
In 2018 Douglas K. Anderson was the recipient of the US Congressional Certificate of Recognition and The University of Florida McKnight Brain Institute established the Douglas K. Anderson Facial Pain Research Program to fund future research to find cures for TN and neuropathic pain.
Todd E. Golde, M.D., Ph.D., is executive director of the Evelyn F. and William L. McKnight Brain Institute of the University of Florida. He oversees neuroscience and neuromedicine research programs across the University of Florida campus.
John K. Neubert, D.D.S., Ph.D., is the principal investigator for the scientific research project entitled Mapping Towards a Cure: Identification of Neurophysiologic Signatures of Trigeminal Neuralgia Pain
Dr. Basbaum spoke by telephone from San Francisco with Mervyn Rothstein, who was an editor and writer at The New York Times for 29 years before retiring in 2010.
"I’m more committed to solving the problem than I am to any particular solution. So if it turns out that we can discover the origins of this condition it may well be that surgery may not be the ultimate answer."